Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
VEC-H52H3 | Human | Human VEGF-C / Flt4-L Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Human VEGF-C Protein, His Tag (Cat. No. VEC-H52H3) capture on NTA-Series S sensor chip can bind Human VEGF R3, Fc Tag (Cat. No. FL4-H5251) with an affinity constant of 0.130 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
The purity of Human VEGF-C Protein, His Tag (Cat. No. VEC-H52H3) is more than 90% and the molecular weight of this protein is around 30-45 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
VEGF-C gene therapy (Herantis Pharma) | Ad-VEGF-C; LX-1101 | Herantis Pharma | Details | ||
Sozinibercept | OPT-302; VGX-300 | Phase 3 Clinical | Orphan Europe Sarl | Neovascularization, Pathologic; Retinal Diseases; Diabetic macular oedema; Retinal Degeneration; Eye Diseases; Macular Degeneration | Details |
IBI-333 | IBI-333 | Phase 1 Clinical | Innovent Biologics (Usa), Inc | Wet Macular Degeneration; Macular Degeneration | Details |
This web search service is supported by Google Inc.